Derivation of an in vivo drug exposure breakpoint for flucytosine against candida albicans and impact of the mic, growth rate, and resistance genotype on the antifungal effect

William W. Hope, Peter A. Warn, Andrew Sharp, Susan Howard, Miki Kasai, Arnold Louie, Thomas J. Walsh, George L. Drusano, David W. Denning

Research output: Contribution to journalArticlepeer-review

24 Scopus citations

Fingerprint

Dive into the research topics of 'Derivation of an in vivo drug exposure breakpoint for flucytosine against candida albicans and impact of the mic, growth rate, and resistance genotype on the antifungal effect'. Together they form a unique fingerprint.

Medicine & Life Sciences